Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Adjuvant phytotherapy for Parkinson's disease

Oct. 24, 2006

European CHMP issues positive opinion on Diacomit submission

Oct. 23, 2006

Seroquel SR filed for approval in Canada, E.U.

Oct. 23, 2006

Differential modulation of mGluR5 activity yields therapeutic potential in CNS disorders

Oct. 23, 2006

Recent patents describe novel agents for anxiety, depression, psychosis, etc.

Oct. 23, 2006

Positive phase III findings for Transacin in postherpetic neuralgia

Oct. 23, 2006

Enrollment complete in first stage of phase II ALS trial of ALS-08

Oct. 23, 2006

Gantacurium pharmacodynamics assessed in phase II trial

Oct. 23, 2006

Recent data on HDAC inhibitors in neurological conditions

Oct. 23, 2006

Recent BiRDS Pharma patent describes new therapeutic agents for muscle spasm

Oct. 20, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...